Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $79.0800 (24.79%) ($57.2400 - $84.1800) on Tue. Mar. 17, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.39% (three month average) | RSI | 42 | Latest Price | $79.0800(24.79%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -4.6% a day on average for past five trading days. | Weekly Trend | LGND declines -11.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(58%) IWC(55%) XBI(55%) IWM(54%) | Factors Impacting LGND price | LGND will decline at least -2.695% in a week (0% probabilities). VIXM(-33%) VXX(-20%) TLT(-13%) UUP(-5%) SHY(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.695% (StdDev 5.39%) | Hourly BBV | 0 () | Intraday Trend | 22.8% | | | |
|
1 - 5 Day Possible Target | $65(-17.8%) | Resistance Level | $95.55 | 5 Day Moving Average | $79.57(-0.62%) | 10 Day Moving Average | $90.46(-12.58%) | 20 Day Moving Average | $95.55(-17.24%) | To recent high | -27.5% | To recent low | 24.8% | Market Cap | $1.271b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |